{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:34:05Z","timestamp":1762079645963,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.04.033","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T22:52:04Z","timestamp":1528152724000},"page":"4375-4382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial"],"prefix":"10.1016","volume":"36","author":[{"given":"M.","family":"Tashani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alfelali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Barasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Heron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Findlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Booy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.04.033_b0005","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2018.04.033_b0010","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: clinical presentation and sequelae","volume":"30","author":"Pace","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0015","first-page":"237","article-title":"Meningococcal disease: changes in epidemiology and prevention","volume":"4","author":"Chang","year":"2012","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2018.04.033_b0020","article-title":"Meningococcal disease","volume":"2015","author":"Becka","year":"2015","journal-title":"J Infect Dis Therapy"},{"key":"10.1016\/j.vaccine.2018.04.033_b0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","article-title":"Prospects for vaccine prevention of meningococcal infection","volume":"19","author":"Harrison","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2018.04.033_b0030","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.1016\/j.vaccine.2011.12.060","article-title":"History of meningococcal vaccines and their serological correlates of protection","volume":"30","author":"Vipond","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0035","unstructured":"Centers for Disease Control and Prevention. Immunization Schedules: Child and Adolescent Schedule. Available from <http:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-adolescent.html>. [accessed in November 2016]."},{"key":"10.1016\/j.vaccine.2018.04.033_b0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jadohealth.2013.05.009","article-title":"Missed opportunities for adolescent vaccination, 2006\u20132011","volume":"53","author":"Wong","year":"2013","journal-title":"J Adolesc Health."},{"key":"10.1016\/j.vaccine.2018.04.033_b0045","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2018.04.033_b0050","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2014.01.047","article-title":"Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines","volume":"32","author":"Pobre","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0055","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants","volume":"27","author":"Pollabauer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CVI.00314-12","article-title":"Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine","volume":"20","author":"Ceyhan","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.04.033_b0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3201\/eid0808.010422","article-title":"Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000","volume":"8","author":"Aguilera","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.033_b0070","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(02)07716-4","article-title":"W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001","volume":"359","author":"Hahne","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.04.033_b0075","unstructured":"Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj), 2016. Wkly Epidemiol Rec. 2016;91:331\u20135."},{"key":"10.1016\/j.vaccine.2018.04.033_b0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.tmaid.2013.06.001","article-title":"The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion","volume":"11","author":"Rashid","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.033_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2016.02.005","article-title":"Exploring barriers to and facilitators of preventive measures against infectious diseases among Australian Hajj pilgrims: cross-sectional studies before and after Hajj","author":"Alqahtani","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.033_b0090","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1016\/j.vaccine.2016.10.020","article-title":"Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: a randomised controlled trial","volume":"34","author":"Tashani","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0095","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI). The Australian immunisation handbook 10th ed (2015 update). Canberra: Australian Government Department of Health; 2015."},{"key":"10.1016\/j.vaccine.2018.04.033_b0100","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.04.033_b0105","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(96)91456-7","article-title":"Diphtheria immunity in health staff","volume":"347","author":"John","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.04.033_b0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0092-1157(86)90008-9","article-title":"ELISA for the routine determination of antitoxic immunity to tetanus","volume":"14","author":"Simonsen","year":"1986","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2018.04.033_b0115","doi-asserted-by":"crossref","unstructured":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2000. Commun Dis Intell.25:274\u20136.","DOI":"10.33321\/cdi.2001.25.47"},{"key":"10.1016\/j.vaccine.2018.04.033_b0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.vaccine.2003.09.007","article-title":"Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation","volume":"22","author":"Marcy","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0125","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2010.02.045","article-title":"Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines","volume":"28","author":"Arguedas","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0130","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00267-16","article-title":"Higher immune responses observed in United States military personnel who received meningococcal conjugate vaccine concomitantly with other vaccines","author":"Broderick","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.04.033_b0135","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.04.033_b0140","first-page":"85","article-title":"Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease","volume":"7","author":"Hedari","year":"2014","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2018.04.033_b0145","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3349\/ymj.2016.57.6.1511","article-title":"Immunogenicity of MenACWY-CRM in Korean military recruits: influence of tetanus-diphtheria toxoid vaccination on the vaccine response to MenACWY-CRM","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.vaccine.2018.04.033_b0150","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1016\/j.vaccine.2011.03.009","article-title":"An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix hexa is immunogenic, with an acceptable safety profile in 12\u201323-month-old children","volume":"29","author":"Knuf","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0155","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/iai.59.10.3504-3510.1991","article-title":"Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines","volume":"59","author":"Peeters","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.04.033_b0160","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.vaccine.2010.11.057","article-title":"Immunogenicity and reactogenicity of co-administered tetanus-diphtheria-acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration","volume":"29","author":"Weston","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0165","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/01.inf.0000145427.19167.35","article-title":"Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine","volume":"23","author":"Tejedor","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.04.033_b0170","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1016\/j.vaccine.2010.02.103","article-title":"Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies","volume":"28","author":"Jegerlehner","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.03.055","article-title":"Carrier priming effect of CRM is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM and diphtheria toxoid","author":"Pecetta","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0180","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.142.8.2635","article-title":"Carrier-induced epitopic suppression is initiated through clonal dominance","volume":"142","author":"Schutze","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.04.033_b0185","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0190","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.vaccine.2015.04.094","article-title":"Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine","volume":"33","author":"Zhang","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0195","first-page":"83","article-title":"Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A\/C polysaccharide vaccination in Saudi Arabia","volume":"11","author":"Jokhdar","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2018.04.033_b0200","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CVI.00516-10","article-title":"Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age","volume":"18","author":"Miller","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.04.033_b0205","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/S0264-410X(03)00058-6","article-title":"Effect of infant immunisation with meningococcus serogroup C-CRM(197) conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children","volume":"21","author":"McVernon","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.033_b0210","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4161\/hv.20211","article-title":"The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: a randomized, controlled non-inferiority study","volume":"8","author":"Dbaibo","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.04.033_b0215","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2016.1153206","article-title":"Factors contributing to the immunogenicity of meningococcal conjugate vaccines","author":"Broker","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.04.033_b0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1473-3099(08)70052-5","article-title":"Conjugate versus polysaccharide meningococcal vaccine","volume":"8","author":"Rashid","year":"2008","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18305164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18305164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:03Z","timestamp":1759400883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18305164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":44,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X18305164"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}